Trials / Completed
CompletedNCT07170215
Effect of Anti-gravity Treadmill Training After Total Hip Arthroplasty
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- University of Rijeka · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Background/Objectives: Total hip arthroplasty is one of the most common orthopedic procedures. When the surgery is successful and followed by high-quality physiotherapy, patients' quality of life usually improves and they return to their daily activities more qui-ckly.. Rehabilitation methods and medical devices are constantly evolving, to accelerate functional improvement. The aim of the study is to investigate the impact of the antigra-vity treadmill on the functional outcomes after total hip arthroplasty. Methods: A single centre, randomised, controlled, open label trial was conduct in Hospital for Medical Re-habilitation of the Heart and Lung Diseases and Rheumatism Thalassotherapia Opatija. 34 subjects were randomly divided into two groups: experimental (18) and control (16). The outcome measures included strength of the abductor muscles, range of motion, visual analogue scale, and Timed Up and Go test and 40-meter Fast Paced Walk test.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | antigravity treadmill (ALTERG VIA, Lifeward CA, Inc., Milmont Drive, Fremont, CA, U-SA) | Antigravity treadmill training in the experimental group (EG) involved walking in a straight line at a self-selected, com-fortable pace-without running, shortness of breath, or pain. The treadmill's chamber was set to reduce the participant's effective body weight to 20% of their actual body weight (slight unloading was applied to reduce the need for handrail support and to prevent the use of compensatory mechanisms). |
Timeline
- Start date
- 2023-01-15
- Primary completion
- 2023-07-30
- Completion
- 2023-07-30
- First posted
- 2025-09-12
- Last updated
- 2025-09-12
Locations
1 site across 1 country: Croatia
Source: ClinicalTrials.gov record NCT07170215. Inclusion in this directory is not an endorsement.